patrick lyon

Developed and initiated marketing activities to support US launch of novel atrial fibrillation catheters and capital equipment Led market segmentation, account targeting, pricing analyses and roll-out Built launch model and scorecard to forecast and track financial, operational success Chosen to lead cross-functional team preparing for FDA Circulatory System Devices Panel; worked with clinical, regulatory, and marketing teams in messaging, presentation creation, and Q&A preparation

Determined strategic and financial value of left heart lead and delivery system ($100MM revenue potential); management approved term sheet negotiations

* Built franchise marketing plan to expand blockbuster biotech drug into new therapeutic area * utilized 75+ interviews over 3 disease states to establish cross-indication strategy Conducted business development evaluation for hormone replacement therapy * evaluated sell, license, co-promote, and hybrid models yielding $200MM NPV Analyzed $250MM US pediatric oral steroid market for pharmaceutical M&A due diligence * built patient uptake model and crafted strategy to increase target sales by 50%

Designed and executed investor relations programs to market micro- through large-cap foreign clients' equity to US investors; clients included SAP, BSkyB, Smith+Nephew

Managed global, cross-functional business development teams across Medtronic Evaluated and executed minority investments, mergers & acquisitions, divestitures, and strategic analyses for both corporate-sponsored and business unit initiatives Led and supported all aspects of transactions, including strategic and financial analysis, valuation, deal structuring, negotiation, and due diligence activities Transaction experience included the cardiac rhythm, cardiovascular, diabetes, neurological, spinal, dental, and obesity therapeutic areas

Led gastroenterology business development analysis at life science strategy consultancy, recommended two licensing deals representing $1B+ sales opportunity Directed client market research and marketing teams in defensive strategy generation against competitor launch for blockbuster drug; gained implementation approval Developed pre-launch pricing and community marketing strategy for top pharma to enter $8B AIDS market; gained approval for follow-on implementation engagement